Meet Pittsburgh's newest Nasdaq company, Coeptis Therapeutics
Coeptis is a cell therapy company, targeting the treatment of multiple myeloma, chronic lymphocytic leukemia and other CD38-type cancers by developing cell and gene therapies.
LocalNews
0
38
Coeptis is a cell therapy company, targeting the treatment of multiple myeloma, chronic lymphocytic leukemia and other CD38-type cancers by developing cell and gene therapies.
